Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: A randomized, double-blind, placebo-controlled study

Pain

Volumn 106, Issue 1-2, 2003, Pages 151-158

  Meier, Torsten ^a   Wasner, Gunnar ^b   Faust, Markus ^a   Kuntzer, Thierry ^c   Ochsner, François ^c   Hueppe, Michael ^a   Bogousslavsky, Julien ^c   Baron, Ralf ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Lidocaine; Neuropathic pain; Randomized, double blind, placebo controlled trial; Topical treatment

Indexed keywords

ANALGESIC AGENT; CAPSAICIN; GABAPENTIN; LIDOCAINE; NEURODOL TISSUGEL; PLACEBO;

ADULT; AGED; ALLODYNIA; ARTICLE; CALCULATION; CANCER PAIN; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DATA ANALYSIS; DIABETIC NEUROPATHY; DIAPHORESIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ERUPTION; ECZEMA; ECZEMATOUS FOLLICULITIS; FACE EDEMA; FEMALE; FOLLICULITIS; HEADACHE; HUMAN; HYPEREMIA; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MERALGIA PARESTHETICA; MULTICENTER STUDY; NAUSEA; NERVOUSNESS; NEURALGIA; NEUROPATHIC PAIN; PAIN; PERIPHERAL NEUROPATHY; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; SKIN BURNING SENSATION; SKIN IRRITATION; SLEEP; SURAL NERVE; SWEATING; TACHYCARDIA; VERTIGO; VESICULOBULLOUS RASH; VISUAL ANALOG SCALE;

EID: 0142196073     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(03)00317-8     Document Type: Article

References (30)

1. Attal N., Brasseur L., Chauvin M., Bouhassira D. Effects of single and repeated applications of a eutectic mixture of local anaesthetics (EMLA) cream on spontaneous and evoked pain in post-herpetic neuralgia. Pain. 81:1999;203-209.
2. Benedittis G.D., Lorenzetti A. Topical asparin/diethyl ether mixture versus indomethacin and diclofenac/diethyl ether mixtures for acute herpetic neuralgia and postherpetic neuralgia: a double-blind cross-over placebo-controlled study. Pain. 65:1996;45-51.
3. Brau M.E., Dreimann M., Olschewski A., Vogel W., Hempelmann G. Effect of drugs used for neuropathic pain management on tetrodotoxin-restitant Na+ currents in rat sensory neurons. Anesthesiology. 94:2001;137-144.
4. Carter G.T., Galer B.S. Advances in the management of neuropathic pain. Phys Med Rehabil Clin N Am. 12:2001;447-459.
5. Cohen J. Statistical power analysis for behavioural sciences. 1988;Erlbaum, Hillsdale.
6. Cook R.J., Sackett D.L. The number needed to treat: a clinically useful measure of treatment effect. Br Med J. 310:1995;452-454.
7. Devers A., Galer B.S. Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open label study. Clin J Pain. 16:2000;205-208.
8. Dworkin R.H. An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms. Clin J Pain. 18:2002;343-349.
9. Galer B.S. Neuropathic pain of peripheral origin: advances in pharmacologic treatment. Neurology. 45:1995;S17-S25.
10. Galer B.S., Hendersson J., Perander J., Jensen M.P. Course of symptoms and quality of life measurement in complex regional pain syndrome: a pilot survey. J Pain Symptom Manage. 20:2000;286-292.
11. Galer B.S., Jensen M.P. Development and preliminary validation of a pain measure specific to neuropathic pain: the neuropathic pain scale. Neurology. 48:1997;332-338.
12. Galer B.S., Jensen M.P., Ma T., Davies P.S., Rowbotham M.C. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain. 18:2002;297-301.
13. Galer B.S., Rowbotham M.C., Perander J., Friedmann E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrolment study. Pain. 80:1999;533-538.
14. Gammaitoni A.R., Alvarez N.A., Galer B.S. Safety and tolerability of lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature. J Clin Pharmacol. 43:2003;111-117.
15. Gammaitoni A.R., Davis M.W. Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing. Ann Pharmacother. 36:2002;236-240.
16. Jensen T.S., Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain. Pain. 102:2003;1-8.
17. Kingery W.S. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain. 73:1997;123-139.
18. Meyer-Rosberg K., Kvarnström A., Kinnmann E., Gorth T., Nordfors L.O., Kristofferson A. Peripheral neuropathic pain - a multidimensional burden for patients. Eur J Pain. 5:2001;379-389.
19. Moore R.A., Gavaghan D., Tramèr M.R., Collins S.L., McQuay H.J. Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain. 78:1998;209-216.
20. Nelson D.A., Landau W.M. Intrathecal methylprednisolone for postherpetic neuralgia. N Engl J Med. 344:2001;1019-1022.
21. Raja S.N., Haythornthwaite J.A., Pappagallo M., Clark M.R., Travison T.G., Sabeen S., Royall R.M., Max M.B. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 59:2002;1015-1021.
22. Rice A.S.C., Maton S. Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: a randomized, double blind, placebo controlled study. Pain. 94:2001;215-224.
23. Rowbotham M.C., Davies P.S., Fields H.L. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol. 37:1995;246-253.
24. Rowbotham M.C., Davies P.S., Verkempinck C.M., Galer B.S. Lidocaine patch: double-blind controlled study of a new treatment method for postherpetic neuralgia. Pain. 65:1996;39-44.
25. Rowbotham M., Harden N., Stacey B., Bernstein P., Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA. 280:1998;1837-1842.
26. Serpell M.G. Neuropathic Pain Study Group. Gabapentin in neuropathic pain syndrome: a randomized, double-blind, placebo-controlled trial. Pain. 99:2002;557-566.
27. Sindrup H.S., Jensen T.S. Efficacy of pharmacolocigal treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain. 83:1999;389-400.
28. Watson C.P. Topical capsaicin as an adjuvant analgesic. J Pain Symptom Manage. 9:1994;425-433.
29. Watson C.P., Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology. 50:1998;1837-1841.
30. Watson C.P., Evans R.J. The post-mastectomy pain syndrome and topical capsaicin: a randomized trial. Pain. 51:1992;375-379.